ArticleMaterials today. Bio2025
Reverse biogradient biomimetic periosteum with osteogenic and angiogenic characteristics for bone regeneration.
Article in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A bioprinted periosteum organoid enables functional repair of critical-sized bone defects.Bioactive materials · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The periosteum is critical for bone reconstruction. Despite serving as a clinical "induced periosteum" treatment for bone defects, the induced membrane technique is associated with significant psychological distress and economic burden due to the need for secondary surgery. Inspired by the ability of induced membranes to function like the periosteum, we propose a tissue-engineered periosteum to replace induced membranes for bone regeneration. This study confirmed that the induced membrane and periosteum share similar architectural and biological properties, including a loose inner layer, a dense outer layer, and a protein expression pattern. An asymmetric nanofibrous membrane was fabricated by electrospinning using gelatin and chitosan, with bone morphogenetic protein (BMP-2) and functionalized hydroxyapatite (Func-HA) incorporated to construct a biomimetic periosteum featuring a reverse biogradient for bone reconstruction and regeneration. The reverse biogradient biomimetic periosteum could significantly enhance osteogenesis and angiogenesis. Interestingly, the biomimetic periosteum also provided a periosteum-mimetic microenvironment by enhancing periosteal stem cells (PSCs) recruitment to the bone defect region and upregulating periostin expression. Our findings suggest that biomimetic membranes with a reverse biogradient could be promising alternatives to induced membranes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.